TrialJCO precision oncology2024

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance.

Ashley E Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.